- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03982888
Deep Brain Stimulation in Children With Autism
Deep Brain Stimulation for the Treatment of Refractory Repetitive Self-Injurious Behaviour in Children With Autism Spectrum Disorder: A Pilot Project
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a phase I, non-blinded, non-randomized, pilot trial for safety and efficacy of deep brain stimulation for medically-refractory, repetitive self-injurious behaviours in children with ASD (i.e. secondary stereotypies). The trial will be conducted in compliance with the protocol, GCP and the applicable regulatory requirement(s).
Patients who meet inclusion and exclusion criteria will be identified and recruited the Neurosurgical Clinic at The Hospital for Sick Children. The study will proceed according to the schedule laid out below, and both patients and treating team will be aware of all treatment parameters at all times. Six (6) subjects will be enrolled in this study and study duration for each patient will be one (1) year. Previous phase I trials of DBS in psychiatric and Alzheimer's Disease populations have utilized 6 subjects per surgical target. Such a number is sufficient to demonstrate initial safety, as well as feasibility and clinical effectiveness.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: George M Ibrahim, MD
- Phone Number: 416-813-6425
- Email: george.ibrahim@sickkids.ca
Study Contact Backup
- Name: Carolina Gorodetsky, MD
- Phone Number: 416-813-6428
- Email: carolina.gorodetsky@sickkids.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female or Male patients between age 7-18
- Diagnosis of Autism Spectrum Disorder (as defined by the DSM-5).
- Failure or non eligibility of medical therapy with ongoing repetitive self-injurious behaviours, at 6 months or more after instigation of therapy. Failure is defined as a lack of improvement in self-injurious behaviours, as documented by objective evidence, including caregiver logs or clinician assessment, if the clinician has documented a baseline status prior to instigation of the medical therapy.
- Diagnosis of secondary stereotypies, based on clinical assessment of the treating physicians with evidence of self-injury, documented in the patient records.
- Parents or legal guardians, including caregivers, informed and able to give written consent.
- Able to comply with all testing, follow-ups and study appointments and protocols for 12 months following the end of the duration of the study.
Exclusion Criteria:
- Substance dependence or abuse in the last 6 months, excluding caffeine and nicotine
- Any contraindication to MRI or PET scanning
- Likely to relocate away from the study site or move during the study's one year duration
- Presence of cardiac arrhythmias, or other cardiac, respiratory, renal or endocrine conditions that will result in significant risk from a surgical procedure.
- Pregnancy
- Unable to communicate adequately in English in order to complete the baseline and follow-up questionnaires.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: DBS Treatment
Deep brain stimulation of both limbic and dysfunctional reward processing circuits for treatment of repetitive self injurious behaviours in children with ASD
|
Stimulation of the nucleus accumbens via 2 electrodes implanted in the brain per patient to reduce self-injurious behaviours.
Use of the Medtronic DBS device. DBS device consists of 2 parts:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in repetitive behaviour
Time Frame: 1 year
|
The Repetitive Behavior Scale-Revised (RBS-R; Bodfish, Symons, Parker & Lewis, 2000) will be used to measure changes in repetitive behaviour pre and post intervention. The following sub-scales will be used:
All subscales are scored from 0-3 as follows: 0 = behaviour does not occur
Subscores are totaled and then an overall score is calculated. Measure will be completed at baseline (pre-surgery), weekly from weeks 2-6 post-surgery, bi-weekly from weeks 7-10 post surgery, monthly from weeks 11-51 post-surgery, and 1 year post surgery. |
1 year
|
Changes in self-injurious behaviour
Time Frame: 1 year
|
The Inventory of Statements about Self-Injury (ISAS; Klonsky & Olino, 2008) will be used to measure changes in self-injurious behaviour pre and post intervention. The scale is scored from 0-2 as follows: 0= not relevant
Measure will be completed at baseline (pre-surgery), weekly from weeks 2-6 post-surgery, bi-weekly from weeks 7-10 post surgery, monthly from weeks 11-51 post-surgery, and 1 year post surgery. |
1 year
|
Changes in abberant behaviour
Time Frame: 1 year
|
The Aberrant Behavior Checklist (Aman, Singh, Stewart & Field, 1985) will be used to measure changes in the extent that abberant behaviour is a problem pre and post intervention. The scale is scored from 0-3 as follows: 0= not at all a problem
Measure will be completed at baseline (pre-surgery), weekly from weeks 2-6 post-surgery, bi-weekly from weeks 7-10 post surgery, monthly from weeks 11-51 post-surgery, and 1 year post surgery. |
1 year
|
Changes in obsessive-compulsive thoughts
Time Frame: 1 year
|
The Yale-Brown Obsessive Compulsive Scale (Y-BOCS; Goodman, Price, Rasmussen,1989) will be used to measure changes in the amount of interference of unwanted ideas, images, or impulses pre and post intervention. The scale is scored from 0-4, where 0 represents minimal interference and 4 represents substantial interference. Questions are scored and totaled. Measure will be completed at baseline (pre-surgery), weekly from weeks 2-6 post-surgery, bi-weekly from weeks 7-10 post surgery, monthly from weeks 11-51 post-surgery, and 1 year post surgery. |
1 year
|
Changes in quality of life
Time Frame: 1 year
|
The Paediatric Quality of Life Inventory (PedsQL v. 4.0) will be used to measure changes in self-reported quality of life pre and post intervention. The statements are scored from 0-4 as follows: 0= it is never a problem 1 = it is almost never a problem 2= it is sometimes a problem 3 = it is often a problem 4= it is almost always a problem Where a higher score indicates the statement is a problem. All items are scored and totaled. Measure will be completed at baseline (pre-surgery), weekly from weeks 2-6 post-surgery, bi-weekly from weeks 7-10 post surgery, monthly from weeks 11-51 post-surgery, and 1 year post surgery. |
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in physical brain abnormalities
Time Frame: 1 year
|
MR images will be analyzed pre and post intervention for the following to assess physical abnormalities of the brain, including type (focal cortical dysplasia, tumor, hippocampal sclerosis, hypothalamic hamartoma, gliosis, brain atrophy), side of abnormalities (left/right/ bilateral), and location (frontal, temporal, sylvian, parietal, occipital, multilobar). MRI data will be collected at baseline, 6 weeks post-surgery, and 1 year post-surgery. |
1 year
|
Changes in metabolic brain abnormalities
Time Frame: 1 year
|
FDG-PET scans will be analyzed to measure changes in neurometabolism pre and post intervention, specifically indications of hypermetabolism in the frontal lobes, hippocampus, and lentiform nucleus. FDG-PET data will be collected at baseline, 6 weeks post-surgery, and 1 year post-surgery. |
1 year
|
Changes in activity
Time Frame: 1 year
|
Changes in activity pre and post intervention will be measured using the Actiwatch Spectrum, Phillips Respironics, Bend, OR.
Actigraphy is the continuous measurement of an individual's movement.
Actigraph data will be collected at baseline, 6 weeks post-surgery, and 1 year post-surgery.
Actigraph data will be analyzed using MATLAB (Mathworks, Natick, MA).
Measures analyzed will be maximum and minimum value amplitudes, peak to peak, variance, entropy fast fourier transform, discrete cosine function, z-transform, bispectrum.
|
1 year
|
Type of adverse events reported in caregiver logs
Time Frame: 1 year
|
1 year
|
|
Changes in number of complications pre and post intervention will be compared.
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: George Ibrahim, MD, The Hospital for Sick Children
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB1000060282
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Self-Injurious Behavior
-
New York State Psychiatric InstituteMINT: Mental Health InitiativeCompletedInterpersonal Psychotherapy for Depressed Adolescents Engaging in Non-suicidal Self-injury (IPT-ASI)Depression | Self-injurious BehaviorUnited States
-
Western Michigan University School of MedicineKalamazoo Community FoundationWithdrawnSelf Mutilation | Self-injurious BehaviorUnited States
-
Hartford HospitalOui Therapeutics, LLCNot yet recruitingSuicidal and Self-injurious BehaviorUnited States
-
White River Junction Veterans Affairs Medical CenterUS Department of Veterans AffairsActive, not recruitingSuicidal and Self-injurious BehaviorUnited States
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedSelf Injurious Behavior Without Suicidal IntentUnited States
-
Region SkaneLund UniversityCompletedSuicidal Ideation | Self-Harm, Deliberate | Self Injurious Behavior Without Suicidal IntentSweden
-
University Hospital, MontpellierRecruitingMajor Depressive Episode | Suicidal and Self-injurious BehaviorFrance
-
Rutgers, The State University of New JerseyRecruiting
-
University Medical Centre MariborFaculty of Medicine, University of MariborCompletedSelf-Injurious Behavior | Self Injurious Behavior Without Suicidal Intent
-
Northeastern UniversityHarvard School of Public Health (HSPH); American Foundation for Suicide Prevention and other collaboratorsCompletedSuicidal and Self-injurious BehaviorUnited States
Clinical Trials on Deep Brain Stimulation
-
Abbott Medical DevicesTerminatedDepressive Disorder, Major | Unipolar DepressionUnited States, Canada, United Kingdom
-
Zhiqi MaoRecruitingParkinson's Disease | Executive Function | Electroencephalogram | Functional Near - Infrared SpectroscopyChina
-
Ali Rezai, MDCompleted
-
University Hospital Inselspital, BerneCompletedMovement Disorder | Urinary Tract DiseaseSwitzerland
-
University of MinnesotaRecruitingParkinson DiseaseUnited States
-
NewronikaTerminatedParkinson DiseaseItaly
-
Butler HospitalMedtronicCompletedObsessive-Compulsive DisorderUnited States
-
Qilu Hospital of Shandong UniversityRecruiting
-
University of Sao Paulo General HospitalUnknownCerebellar AtaxiaBrazil
-
Boston Scientific CorporationCompletedParkinson's DiseaseUnited States